Recent advances in sortase-catalyzed ligation methodology
- PMID: 27318815
- PMCID: PMC5010448
- DOI: 10.1016/j.sbi.2016.05.021
Recent advances in sortase-catalyzed ligation methodology
Abstract
The transpeptidation reaction catalyzed by bacterial sortases continues to see increasing use in the construction of novel protein derivatives. In addition to growth in the number of applications that rely on sortase, this field has also seen methodology improvements that enhance reaction performance and scope. In this opinion, we present an overview of key developments in the practice and implementation of sortase-based strategies, including applications relevant to structural biology. Topics include the use of engineered sortases to increase reaction rates, the use of redesigned acyl donors and acceptors to mitigate reaction reversibility, and strategies for expanding the range of substrates that are compatible with a sortase-based approach.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Nothing declared for JMA and MCT. HLP is a co-founder of and owns stock in 121Bio, a company that uses sortase for protein modification.
Figures
References
-
- Mao H, Hart SA, Schink A, Pollok BA. Sortase-mediated protein ligation: a new method for protein engineering. J Am Chem Soc. 2004;126:2670–2671. - PubMed
-
- Chen Q, Sun Q, Molino NM, Wang S-W, Boder ET, Chen W. Sortase A-mediated multi-functionalization of protein nanoparticles. Chem Commun. 2015;51:12107–12110. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
